Cargando…

Potential Role of Cuproptosis-Related Lncrna in Prognosis and Immunotherapy of Thyroid Carcinoma

BACKGROUND: Cuproptosis-related long non-coding RNA (lncRNA) disease is associated with the development and progression of tumors. We aimed to investigate the prediction of cuproptosis-related lncRNA on the prognosis and immunotherapy of patients with thyroid carcinoma (THCA). METHODS: The thyroid c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yunying, Niu, Ben, Gao, Jie, Su, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362200/ https://www.ncbi.nlm.nih.gov/pubmed/37484723 http://dx.doi.org/10.18502/ijph.v52i5.12718

Ejemplares similares

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma
por: Pang, Yipeng, et al.
Publicado: (2023)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
por: Liangyu, Zhu, et al.
Publicado: (2023)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma
por: Wang, Fangwei, et al.
Publicado: (2022)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer
por: Kong, Xiaoyu, et al.
Publicado: (2023)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis
por: Yin, Chunlin, et al.
Publicado: (2023)

Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer
por: He, Rong, et al.
Publicado: (2023)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
por: Nie, Guilin, et al.
Publicado: (2023)

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
por: Luo, Lan, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

Cuproptosis-related lncRNA SNHG16 as a biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Han, Baoai, et al.
Publicado: (2023)

The role of cuproptosis-related gene in the classification and prognosis of melanoma
por: Liu, Jin-Ya, et al.
Publicado: (2022)

A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer
por: Feng, Anqi, et al.
Publicado: (2022)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bnfs383e6sajtk9orv9j6lgnl4